MAP2K4 and colorectal carcinoma: Patients with CRC exhibited reduced activity of the protein encoded by the MAP2K4 gene compared to healthy individuals; moreover, this loss of activity correlated with the occurrence of cancer metastases to lymph nodes and distant organs and with the clinical stage of the primary cancer.